BG61697B1 - Пептиди с органопредпазна активност, метод за тяхнотополучаване и терапевтичното им приложение - Google Patents

Пептиди с органопредпазна активност, метод за тяхнотополучаване и терапевтичното им приложение Download PDF

Info

Publication number
BG61697B1
BG61697B1 BG98907A BG9890794A BG61697B1 BG 61697 B1 BG61697 B1 BG 61697B1 BG 98907 A BG98907 A BG 98907A BG 9890794 A BG9890794 A BG 9890794A BG 61697 B1 BG61697 B1 BG 61697B1
Authority
BG
Bulgaria
Prior art keywords
peptide
seq
pro
peptides
pro pro
Prior art date
Application number
BG98907A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG98907A (bg
Inventor
Predrag Sikiric
Marijan Petek
Sven Seiwerth
Zeljko Grabarevic
Ivo Rotkvic
Marko Duvnjak
Branko Turkovic
Stjepan Mise
Ernest Suchanek
Boris Mildner
Ivan Udovicic
Original Assignee
Predrag Sikiric
Marijan Petek
Sven Seiwerth
Zeljko Grabarevic
Ivo Rotkvic
Marko Duvnjak
Branko Turkovic
Stjepan Mise
Ernest Suchanek
Boris Mildner
Ivan Udovicic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Predrag Sikiric, Marijan Petek, Sven Seiwerth, Zeljko Grabarevic, Ivo Rotkvic, Marko Duvnjak, Branko Turkovic, Stjepan Mise, Ernest Suchanek, Boris Mildner, Ivan Udovicic filed Critical Predrag Sikiric
Publication of BG98907A publication Critical patent/BG98907A/bg
Publication of BG61697B1 publication Critical patent/BG61697B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BG98907A 1992-11-16 1994-07-15 Пептиди с органопредпазна активност, метод за тяхнотополучаване и терапевтичното им приложение BG61697B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HR921283 1992-11-16
PCT/EP1993/003217 WO1994011394A2 (en) 1992-11-16 1993-11-16 Peptides with organo-protective activity, process for their preparation and their use in the therapy

Publications (2)

Publication Number Publication Date
BG98907A BG98907A (bg) 1995-05-31
BG61697B1 true BG61697B1 (bg) 1998-03-31

Family

ID=10945833

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98907A BG61697B1 (bg) 1992-11-16 1994-07-15 Пептиди с органопредпазна активност, метод за тяхнотополучаване и терапевтичното им приложение

Country Status (17)

Country Link
EP (1) EP0624164B1 (cs)
JP (1) JP2812803B2 (cs)
AT (1) ATE163131T1 (cs)
AU (1) AU5624994A (cs)
BG (1) BG61697B1 (cs)
CA (1) CA2127553C (cs)
CZ (1) CZ285155B6 (cs)
DE (1) DE69316974T2 (cs)
ES (1) ES2114170T3 (cs)
GR (1) GR3026478T3 (cs)
HU (3) HUT66303A (cs)
PL (1) PL304666A1 (cs)
RO (1) RO115733B1 (cs)
RU (1) RU2116311C1 (cs)
SI (1) SI9300595B (cs)
SK (1) SK279227B6 (cs)
WO (1) WO1994011394A2 (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1166683C (zh) * 1997-05-23 2004-09-15 普雷德拉格·西基瑞克 具有器官保护活性的新的bpc肽盐,其制备方法及其在治疗中的应用
SI24318A (sl) * 2013-03-13 2014-09-30 Diagen D.O.O. Nove stabilne soli pentadekapeptida, postopek za njihovo pripravo, njihova uporaba za izdelavo farmacevtskih pripravkov in njihova uporaba v terapiji

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU176089A (sh) * 1989-09-12 1992-09-07 Sikirić, Predrag Postupak za pripremu supstancije bpc i supstancija bpc
WO1992017195A1 (en) 1991-04-08 1992-10-15 Magainin Pharmaceuticals, Inc. Novel peptide compositions and uses therefor
ES2103854T3 (es) * 1992-05-30 1997-10-01 Sikiric Predrag Peptidos con actividad organo protectiva, procedimiento para la preparacion de los mismos y su utilizacion en la terapia.

Also Published As

Publication number Publication date
PL304666A1 (en) 1995-01-09
ATE163131T1 (de) 1998-02-15
SI9300595B (sl) 2003-04-30
CA2127553C (en) 2003-01-28
WO1994011394A2 (en) 1994-05-26
DE69316974D1 (de) 1998-03-19
EP0624164A1 (en) 1994-11-17
DE69316974T2 (de) 1998-07-16
WO1994011394A3 (en) 1994-09-15
HU211260A9 (en) 1995-11-28
HUT66303A (en) 1994-11-28
JPH07507568A (ja) 1995-08-24
SK85794A3 (en) 1995-01-12
JP2812803B2 (ja) 1998-10-22
RO115733B1 (ro) 2000-05-30
CZ162294A3 (en) 1995-02-15
BG98907A (bg) 1995-05-31
HU9401952D0 (en) 1994-09-28
GR3026478T3 (en) 1998-06-30
SI9300595A (en) 1994-09-30
EP0624164B1 (en) 1998-02-11
SK279227B6 (sk) 1998-08-05
HUT67982A (en) 1995-05-29
AU5624994A (en) 1994-06-08
RU94037232A (ru) 1996-06-20
RU2116311C1 (ru) 1998-07-27
CZ285155B6 (cs) 1999-05-12
CA2127553A1 (en) 1994-05-26
ES2114170T3 (es) 1998-05-16
HU9303247D0 (en) 1994-03-28

Similar Documents

Publication Publication Date Title
JP3266311B2 (ja) 新規ポリペプチドおよびこれを用いる抗ｈｉｖ剤
CA2114313C (en) Bpc peptides, their preparation and use
FR2458538A1 (fr) Derives nonapeptidiques et decapeptidiques de l'hormone liberant l'hormone luteinisante, leur procede de production et composition pharmaceutique les contenant
BG61697B1 (bg) Пептиди с органопредпазна активност, метод за тяхнотополучаване и терапевтичното им приложение
AU694701B2 (en) Peptides with organo-protective activity, their preparation and use
AU678917B2 (en) Peptides with organo-protective activity, their preparation and use
US5668109A (en) Peptides for inhibiting pepsin release
AU2018293467A1 (en) Pro-drug peptide with improved pharmaceutical properties
JPS6136298A (ja) トリペプチドアミド類
HUT70179A (en) Process for producing retroinverted tetrapeptides and pharmaceutical compositions containing them as active component
HK1001004B (en) Bpc peptides, their preparation and use
JPS6330499A (ja) オピオイドペプチド・ポリペプチド複合体